Can medical cannabis assist with HIV-related neuropathic pain?

PostedFebruary 17, 2026

UpdatedFebruary 17, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Yes, there is growing evidence that medical cannabis for HIV neuropathic pain can be an effective part of symptom management. HIV-related neuropathy is a common complication caused by the virus itself or as a side effect of antiretroviral medications. It typically presents burning, tingling, or stabbing pain in the hands and feet, often severely affecting quality of life.

Traditional treatments for HIV neuropathy may not always provide adequate relief, leading many patients to explore medical cannabis for HIV neuropathic pain as a complementary option.

How Cannabis May Help with HIV-Related Nerve Pain

Cannabis works by engaging the body’s endocannabinoid system, which plays a crucial role in pain modulation, inflammation, and nerve signalling. Here’s how it may benefit patients with HIV neuropathy:

Pain relief through CB1 and CB2 receptors

Cannabinoids like THC and CBD interact with receptors in the nervous system to reduce the perception of pain, supporting the use of cannabis for HIV nerve pain in managing both constant and breakthrough discomfort.

Anti-inflammatory properties

Inflammation can worsen nerve damage. Cannabis may reduce neuroinflammation, contributing to broader HIV neuropathy with cannabis treatment outcomes beyond just temporary relief.

Improved sleep and anxiety reduction

Chronic nerve pain often disrupts sleep and increases stress. Medical cannabis can support mental wellbeing, helping patients sleep better and manage mood symptoms.

Enhanced quality of life

For many individuals living with HIV, incorporating medical marijuana for HIV neuropathic pain into their treatment plan provides a greater sense of control over their symptoms and daily functioning.

In summary, medical cannabis for HIV neuropathic pain is a promising option for patients who have not found success with conventional therapies. As always, treatment should be guided by a knowledgeable clinician familiar with both HIV care and cannabinoid medicine.

If you’re exploring cannabis treatment options for neuropathic pain, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and neuropathic pain

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.